Diego López-Macías

Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer

Óscar Arrieta, Diego López-Macías, David Orta et al. · The Oncologist · 2015 · 88 citations · Full text

Medicine, Oncology, Pharmacology +16

Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients

Óscar Arrieta, María Teresa de Jesús Vega-González, Diego López-Macías et al. · Lung Cancer · 2015 · 67 citations

Pharmacy, Oncology, Pharmacology +11

A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma

Óscar Arrieta, Diego López-Macías, Víctor-Osvaldo Mendoza-García et al. · Cancer Chemotherapy and Pharmacology · 2014 · 30 citations

Medicine, Oncology, Pharmacology +17

Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial

Óscar Arrieta, Norma Hernández‐Pedro, F. Maldonado et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 10 citations

Medicine, Oncology, Radiation Oncology +16